(Press-News.org) Contact information: Marie Thoms
methoms@alaska.edu
907-474-7412
University of Alaska Fairbanks
Study: Death by moonlight? Not always
Is moonlight dangerous? It depends on what you are, according to a study published online recently in the Journal of Animal Ecology.
"Ecologists have long viewed the darkness of a moonless night as a protective blanket for nocturnal prey species," said Laura Prugh, a wildlife biologist at the University of Alaska Fairbanks.
In the dark, creatures of the night can go about their business in relative safety from lurking predators. Moonlight, according to this logic, helps predators find their prey and is risky if you are a prey species trying not to get eaten.
That's not always so, says Prugh, a researcher with the UAF Institute of Arctic Biology, and colleague Christopher Golden of Harvard University.
"The theory that moonlight increases predation risk ignores the fact that prey animals also have eyes, and they often use them to detect predators," said Prugh. If moonlight helps predators to find prey, it could also help prey species to detect approaching predators.
To find out if moonlit nights are dangerous, Prugh and Golden compiled the effects of moonlight reported in existing studies of 58 nocturnal mammal species. If moonlight is dangerous for prey species, they expected predators to be more active on moonlit nights and prey species to be less active.
The researchers found that species ranged widely in their affinity for moonlight, from the moon-loving or lunar-philic lemurs of Madagascar to the lunar-phobic kangaroo rats in the southwestern United States. And, responses to moonlight were related to the sensory systems of species rather than their positions in the food chain.
Prey animals that use vision as their main sensory system, such as primates, were generally more active on bright nights. Prey species that rely mainly on senses like smell or echolocation, such as many rodents and bats, were generally less active. And contrary to expectations, predators such as African lions were less active on moonlit nights.
"Moonlight is indeed risky for some prey species, but only those that use vision as a backup system rather than their first line of defense," said Prugh. "Our synthesis shows that moonlight can benefit visually oriented prey." And as for those lurking predators, the moon may often hurt rather than help their chances of catching prey.
This study is the first to examine moonlight effects across a diverse assemblage of species. Nearly half of all mammals are nocturnal, experiencing lunar cycles that cause light levels to change by three orders of magnitude every month.
"Our results suggest that moonlight alters predator-prey relations in more complex ways than previously thought," said Prugh, who added that she hopes this study will stimulate further research.
"Do lunar cycles affect population growth rates? How do artificial lights affect the hunting success and vulnerability of nocturnal species? These are important questions that we do not currently have answers to," Prugh said.
INFORMATION:
ADDITIONAL CONTACTS: Laura Prugh, lprugh@alaska.edu, 907-474-5965, is a wildlife biologist at the Institute of Arctic Biology and Department of Biology and Wildlife at the University of Alaska Fairbanks. Her research focuses on wildlife community ecology.
Study: Death by moonlight? Not always
2013-10-22
ELSE PRESS RELEASES FROM THIS DATE:
High school student discovers skeleton of baby dinosaur
2013-10-22
High school student discovers skeleton of baby dinosaur
VIDEO:
This video contains an artist's rendition of the baby Parasaurolophus nicknamed "Joe. ...
New biomarker may help guide treatment of melanoma patients
2013-10-22
New biomarker may help guide treatment of melanoma patients
BOSTON — A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers, according ...
Rapid method to detect BRAF mutations in cancer tissue samples
2013-10-22
Rapid method to detect BRAF mutations in cancer tissue samples
BOSTON — A new diagnostic platform to detect BRAF mutations in melanoma and other cancer types is faster and more accurate compared with the standard method currently used in clinics, ...
Investigational PARP inhibitor promising in BRCA-related cancers
2013-10-22
Investigational PARP inhibitor promising in BRCA-related cancers
BOSTON — An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, ...
Bio-Rad's Droplet Digital PCR technology highlighted at ASHG Annual Meeting
2013-10-22
Bio-Rad's Droplet Digital PCR technology highlighted at ASHG Annual Meeting
Researchers use Droplet Digital PCR assays to obtain promising results in new copy number variation studies
Hercules, CA – October 22, 2013 – More accurate and precise assessment of copy number variation ...
Numerical validation of quantum magnetic ordering
2013-10-22
Numerical validation of quantum magnetic ordering
Numerical simulations designed to confirm the magnetic characteristics of 3D quantum materials largely match the theoretical predictions
A new study set out to use numerical simulations to validate previous theoretical ...
A fresh solution for the lindane problem
2013-10-22
A fresh solution for the lindane problem
The UPV/EHU-University of the Basque Country and Tecnalia are seeking fresh solutions by means of iron nanoparticles to eliminate the consequences of lindane manufacture and use.
For many years two companies located in Bizkaia, ...
New program makes prostate cancer treatment decisions easier
2013-10-22
New program makes prostate cancer treatment decisions easier
When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active ...
Coffee consumption reduces risk of liver cancer
2013-10-22
Coffee consumption reduces risk of liver cancer
Bethesda, MD (Oct. 22, 2013) -- Coffee consumption reduces risk of hepatocellular carcinoma (HCC), the most common type of liver cancer, by about 40 percent, according to an up-to-date meta-analysis published ...
Sequential GO and chemotherapy no benefit for older AML patients according to EORTC/GIMEMA trial
2013-10-22
Sequential GO and chemotherapy no benefit for older AML patients according to EORTC/GIMEMA trial
Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential ...